ARTG 408013NLF System Kits - Autologous adipose tissue collection/injection set
ARTG ID: 408013 · I-Medix Pty Ltd · Euromi SA · Class IIa · Started April 24, 2023
Good Name: I-Medix Pty Ltd - NLF System Kits - Autologous adipose tissue collection/injection set
- Risk Class
- Class IIa
- Product Type
- Medical device system
- ARTG Category
- General
- ARTG ID
- 408013
- Start Date
- April 24, 2023
- Effective Date
- April 24, 2023
- Name
- I-Medix Pty Ltd
- Name
- Euromi SA
- Country
- Belgium
- Address
- Zoning Industriel des Plenesses, Avenue des nouvelles technologies, Andrimont, 11 B-4821
The NLF System® sterile fat cell and collection kit is used during surgical procedures, including liposuction, for removing tissues and/or liquids from the body and injecting autologous adipose tissues, “lipofilling”, for aesthetic body contouring purposes.
Access comprehensive regulatory information for NLF System Kits - Autologous adipose tissue collection/injection set in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is registered under ARTG number 408013 and sponsored by I-Medix Pty Ltd, manufactured by Euromi SA in Belgium. The device registration started on April 24, 2023.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.